Xvivo Perfusion AB (publ) (0RKL.L)
0RKL.L Stock Price Chart
Explore Xvivo Perfusion AB (publ) interactive price chart. Choose custom timeframes to analyze 0RKL.L price movements and trends.
0RKL.L Company Profile
Discover essential business fundamentals and corporate details for Xvivo Perfusion AB (publ) (0RKL.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
8 Dec 2016
Employees
193.00
Website
https://www.xvivoperfusion.comCEO
Christoffer Rosenblad
Description
Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.
0RKL.L Financial Timeline
Browse a chronological timeline of Xvivo Perfusion AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 22 Apr 2026
Upcoming earnings on 26 Jan 2026
Upcoming earnings on 22 Oct 2025
Earnings released on 11 Jul 2025
EPS came in at kr 0.05 falling short of the estimated kr 0.39 by -87.31%, while revenue for the quarter reached kr 219.30M, missing expectations by -10.73%.
Earnings released on 24 Apr 2025
EPS came in at -kr 0.39 falling short of the estimated kr 0.79 by -150.14%, while revenue for the quarter reached kr 218.59M, beating expectations by +2.16%.
Earnings released on 28 Jan 2025
EPS came in at kr 1.15 falling short of the estimated kr 1.38 by -16.67%, while revenue for the quarter reached kr 227.56M, missing expectations by -10.41%.
Earnings released on 24 Oct 2024
EPS came in at kr 2.71 surpassing the estimated kr 0.83 by +226.90%, while revenue for the quarter reached kr 198.48M, missing expectations by -3.54%.
Earnings released on 12 Jul 2024
EPS came in at kr 0.86 surpassing the estimated kr 0.64 by +34.59%, while revenue for the quarter reached kr 210.35M, beating expectations by +8.60%.
Earnings released on 24 Apr 2024
EPS came in at kr 0.72 surpassing the estimated kr 0.39 by +84.20%, while revenue for the quarter reached kr 186.02M, beating expectations by +11.46%.
Earnings released on 25 Jan 2024
EPS came in at kr 2.17 surpassing the estimated kr 0.47 by +363.68%, while revenue for the quarter reached kr 155.74M, missing expectations by -10.16%.
Earnings released on 30 Sept 2023
EPS came in at kr 0.08 falling short of the estimated kr 0.43 by -82.51%, while revenue for the quarter reached kr 146.61M, missing expectations by -6.26%.
Earnings released on 30 Jun 2023
EPS came in at kr 0.23 falling short of the estimated kr 0.35 by -34.50%, while revenue for the quarter reached kr 154.57M, beating expectations by +5.86%.
Earnings released on 31 Mar 2023
EPS came in at kr 0.48 surpassing the estimated kr 0.35 by +36.55%, while revenue for the quarter reached kr 140.62M, beating expectations by +8.61%.
Earnings released on 31 Dec 2022
EPS came in at kr 0.02 falling short of the estimated kr 0.40 by -93.73%, while revenue for the quarter reached kr 131.51M, beating expectations by +12.34%.
Earnings released on 30 Sept 2022
EPS came in at kr 0.18 falling short of the estimated kr 0.22 by -17.31%, while revenue for the quarter reached kr 96.84M, beating expectations by +4.06%.
Earnings released on 30 Jun 2022
EPS came in at kr 0.26 surpassing the estimated kr 0.20 by +29.23%, while revenue for the quarter reached kr 94.29M, missing expectations by -0.02%.
Earnings released on 31 Mar 2022
EPS came in at kr 0.16, while revenue for the quarter reached kr 92.65M.
Dividend declared on 15 Mar 2022
A dividend of kr 0.29 per share was announced, adjusted to kr 0.29.
Earnings released on 31 Dec 2021
EPS came in at kr 0.41 surpassing the estimated -kr 0.14 by +395.65%, while revenue for the quarter reached kr 85.86M, beating expectations by +52.09%.
Earnings released on 30 Sept 2021
EPS came in at -kr 0.04, while revenue for the quarter reached kr 54.94M.
Earnings released on 30 Jun 2021
EPS came in at -kr 0.31, while revenue for the quarter reached kr 59.26M.
Earnings released on 31 Mar 2021
EPS came in at kr 0.20, while revenue for the quarter reached kr 58.33M.
Earnings released on 31 Dec 2020
EPS came in at -kr 0.68, while revenue for the quarter reached kr 60.28M.
Earnings released on 30 Sept 2020
EPS came in at -kr 0.51, while revenue for the quarter reached kr 42.74M.
0RKL.L Stock Performance
Access detailed 0RKL.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.